148 related articles for article (PubMed ID: 24142683)
1. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: Data from the Berlin AFibACS Registry.
Maier B; Hegenbarth C; Theres H; Schoeller R; Schuehlen H; Behrens S;
Cardiol J; 2014; 21(5):465-73. PubMed ID: 24142683
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
[TBL] [Abstract][Full Text] [Related]
3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
5. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
6. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
[TBL] [Abstract][Full Text] [Related]
7. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
9. AFib in special populations.
French WJ
Am J Med; 2014 Apr; 127(4):e17-8. PubMed ID: 24655745
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry).
Rubboli A; Magnavacchi P; Guastaroba P; Saia F; Vignali L; Giacometti P; Franco N; Benassi A; Varani E; Campo G; Manari A; De Palma R; Marzocchi A
Am J Cardiol; 2012 May; 109(10):1411-7. PubMed ID: 22342850
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.
Ho KW; Ivanov J; Freixa X; Overgaard CB; Osten MD; Ing D; Horlick E; Mackie K; Seidelin PH; Džavík V
Can J Cardiol; 2013 Feb; 29(2):213-8. PubMed ID: 23089528
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
[TBL] [Abstract][Full Text] [Related]
15. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
[TBL] [Abstract][Full Text] [Related]
17. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
[TBL] [Abstract][Full Text] [Related]
19. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
[TBL] [Abstract][Full Text] [Related]
20. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
